Literature DB >> 2050037

Expression of the glucocorticoid receptor and K-ras genes in urethan-induced mouse lung tumors and transformed cell lines.

L A Hanson1, E O Nuzum, B C Jones, A M Malkinson, D G Beer.   

Abstract

Glucocorticoids influence cell proliferation and differentiation in the lung. We examined the expression of the glucocorticoid receptor (GR) gene in urethan-induced mouse lung tumors and transformed lung cell lines to determine whether any altered responsiveness to these steroids is involved in the neoplastic development of some lung tumors. We find that a GR mRNA of similar size and amount is expressed in both normal lung and urethan-induced lung tumors. The K-ras gene is activated in urethan-induced lung adenomas and transformed lung cell lines. Both alveolar and papillary lung adenomas express slightly elevated levels of K-ras mRNA and similar levels of H-ras mRNA, but variable levels of c-myc mRNA, GR and K-ras mRNAs are concurrently expressed in a cyclic manner during the proliferation of nontransformed C10 and transformed A5 lung cell lines. Treatment of the C10 cells with dexamethasone (Dex) results in the inhibition of cell proliferation and the down-regulation of both the GR and K-ras mRNA. Dex treatment also down-regulated GR mRNA levels in A5 and LM2 cells, but no inhibitory effect was observed on K-ras mRNA levels or cell proliferation. These results suggest that glucocorticoids can inhibit K-ras expression in nontransformed lung cells. Although transformed lung cells respond to the steroid by down-regulation of the GR, the presence of an activated K-ras allele may override the inhibitory effects of these hormones on cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2050037     DOI: 10.3109/01902149109064425

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  7 in total

1.  Lack of cell surface Fas/APO-1 expression in pulmonary adenocarcinomas.

Authors:  Y Nambu; S J Hughes; A Rehemtulla; D Hamstra; M B Orringer; D G Beer
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

Review 2.  Targeting Nuclear Receptors in Lung Cancer-Novel Therapeutic Prospects.

Authors:  Shailendra Kumar Gangwar; Aviral Kumar; Kenneth Chun-Hong Yap; Sandra Jose; Dey Parama; Gautam Sethi; Alan Prem Kumar; Ajaikumar B Kunnumakkara
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-18

3.  A novel amplicon at 8p22-23 results in overexpression of cathepsin B in esophageal adenocarcinoma.

Authors:  S J Hughes; T W Glover; X X Zhu; R Kuick; D Thoraval; M B Orringer; D G Beer; S Hanash
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

4.  Arsenic alters the function of the glucocorticoid receptor as a transcription factor.

Authors:  R C Kaltreider; A M Davis; J P Lariviere; J W Hamilton
Journal:  Environ Health Perspect       Date:  2001-03       Impact factor: 9.031

5.  Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas.

Authors:  O S Soldes; R D Kuick; I A Thompson; S J Hughes; M B Orringer; M D Iannettoni; S M Hanash; D G Beer
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

6.  E-cadherin expression in primary and metastatic thoracic neoplasms and in Barrett's oesophagus.

Authors:  P F Bongiorno; M al-Kasspooles; S W Lee; W J Rachwal; J H Moore; R I Whyte; M B Orringer; D G Beer
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

7.  Expression and activation of erbB-2 and epidermal growth factor receptor in lung adenocarcinomas.

Authors:  W J Rachwal; P F Bongiorno; M B Orringer; R I Whyte; S P Ethier; D G Beer
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.